Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach

This article is cited by 37 publications.

1. Serdar Durdagi,, Agnes Kapou,, Therapia Kourouli,, Thanos Andreou,, Spyros P. Nikas,, Victoria R. Nahmias,, Demetris P. Papahatjis,, Manthos G. Papadopoulos, and, Thomas Mavromoustakos. The Application of 3D-QSAR Studies for Novel Cannabinoid Ligands Substituted at the C1‘ Position of the Alkyl Side Chain on the Structural Requirements for Binding to Cannabinoid Receptors CB1 and CB2. Journal of Medicinal Chemistry 2007, 50 (12) , 2875-2885. https://doi.org/10.1021/jm0610705
2. Outi M. H. Salo,, Juha R. Savinainen,, Teija Parkkari,, Tapio Nevalainen,, Maija Lahtela-Kakkonen,, Jukka Gynther,, Jarmo T. Laitinen,, Tomi Järvinen, and, Antti Poso. 3D-QSAR Studies on Cannabinoid CB1 Receptor Agonists:  G-Protein Activation as Biological Data. Journal of Medicinal Chemistry 2006, 49 (2) , 554-566. https://doi.org/10.1021/jm0505157
3. Dai Lu,, Zhaoxing Meng,, Ganesh A. Thakur,, Pusheng Fan,, John Steed,, Cindy L. Tartal,, Dow P. Hurst,, Patricia H. Reggio,, Jeffrey R. Deschamps,, Damon A. Parrish,, Clifford George,, Torbjörn U. C. Järbe,, Richard J. Lamb, and, Alexandros Makriyannis. Adamantyl Cannabinoids:  A Novel Class of Cannabinergic Ligands. Journal of Medicinal Chemistry 2005, 48 (14) , 4576-4585. https://doi.org/10.1021/jm058175c
4. Ma. Elena Y. Francisco,, Herbert H. Seltzman,, Anne F. Gilliam,, René A. Mitchell,, Sharyl L. Rider,, Roger G. Pertwee,, Lesley A. Stevenson, and, Brian F. Thomas. Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB1 Receptor Antagonist N-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716). Journal of Medicinal Chemistry 2002, 45 (13) , 2708-2719. https://doi.org/10.1021/jm010498v
5. Maria Fichera,, Gabriele Cruciani,, Alfredo Bianchi, and, Giuseppe Musumarra. A 3D-QSAR Study on the Structural Requirements for Binding to CB1 and CB2 Cannabinoid Receptors. Journal of Medicinal Chemistry 2000, 43 (12) , 2300-2309. https://doi.org/10.1021/jm991074s
6. Alison R. Keimowitz,, Billy R. Martin,, Raj K. Razdan,, Peter J. Crocker,, S. Wayne Mascarella, and, Brian F. Thomas. QSAR Analysis of Δ8-THC Analogues:  Relationship of Side-Chain Conformation to Cannabinoid Receptor Affinity and Pharmacological Potency. Journal of Medicinal Chemistry 2000, 43 (1) , 59-70. https://doi.org/10.1021/jm9902281
7. John W. Huffman,, Shu Yu,, Vincent Showalter,, Mary E. Abood,, Jenny L. Wiley,, David R. Compton,, Billy R. Martin,, R. Daniel Bramblett, and, Patricia H. Reggio. Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 Receptor. Journal of Medicinal Chemistry 1996, 39 (20) , 3875-3877. https://doi.org/10.1021/jm960394y
8. István Ujváry. Hexahydrocannabinol and closely related semi‐synthetic cannabinoids: A comprehensive review. Drug Testing and Analysis 2024, 16 (2) , 127-161. https://doi.org/10.1002/dta.3519
9. Matthew Preteroti, Emily T. Wilson, David H. Eidelman, Carolyn J. Baglole. Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease. Respiratory Research 2023, 24 (1) https://doi.org/10.1186/s12931-023-02399-1
10. Matthew W Preteroti, Hussein Traboulsi, Patrick Greiss, Orsolya Lapohos, Gregory J Fonseca, David H Eidelman, Carolyn J Baglole. Receptor‐mediated effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages. Immunology & Cell Biology 2023, 101 (2) , 156-170. https://doi.org/10.1111/imcb.12614
11. Pradeep Paudel, Samir Ross, Xing-Cong Li. Molecular Targets of Cannabinoids Associated with Depression. Current Medicinal Chemistry 2022, 29 (11) , 1827-1850. https://doi.org/10.2174/0929867328666210623144658
12. Brian F. Thomas. Cannabidiol as a Treatment for Seizures, Convulsions and Epilepsy. 2017, 249-261. https://doi.org/10.1007/978-3-319-54564-6_11
13. Sumner Burstein. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry 2015, 23 (7) , 1377-1385. https://doi.org/10.1016/j.bmc.2015.01.059
14. Patricia H. Reggio. Toward the design of cannabinoid CB 1 receptor inverse agonists and neutral antagonists. Drug Development Research 2009, 70 (8) , 585-600. https://doi.org/10.1002/ddr.20337
15. Dow P. Hurst, Patricia H. Reggio. Models of Cannabinoid Inverse Agonism, Neutral Antagonism, and Agonism: Tools for Rational Drug Design. 2009, 235-278. https://doi.org/10.1007/978-1-59745-503-9_9
16. Ying Pei, Richard W. Mercier, Jenine K. Anday, Ganesh A. Thakur, Alexander M. Zvonok, Dow Hurst, Patricia H. Reggio, David R. Janero, Alexandros Makriyannis. Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation. Chemistry & Biology 2008, 15 (11) , 1207-1219. https://doi.org/10.1016/j.chembiol.2008.10.011
17. Ankur Kapur, Dow P. Hurst, Daniel Fleischer, Rob Whitnell, Ganesh A. Thakur, Alexandros Makriyannis, Patricia H. Reggio, Mary E. Abood. Mutation Studies of Ser7.39 and Ser2.60 in the Human CB 1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB 1 Transmembrane Helix 7. Molecular Pharmacology 2007, 71 (6) , 1512-1524. https://doi.org/10.1124/mol.107.034645
18. Robert P. Picone, Atmaram D. Khanolkar, Wei Xu, Lionel A. Ayotte, Ganesh A. Thakur, Dow P. Hurst, Mary E. Abood, Patricia H. Reggio, Donna J. Fournier, Alexandros Makriyannis. (-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor. Molecular Pharmacology 2005, 68 (6) , 1623-1635. https://doi.org/10.1124/mol.105.014407
19. Rundong Zhang, Dow P. Hurst, Judy Barnett-Norris, Patricia H. Reggio, Zhao-Hui Song. Cysteine 2.59(89) in the Second Transmembrane Domain of Human CB2 Receptor Is Accessible within the Ligand Binding Crevice: Evidence for Possible CB2 Deviation from a Rhodopsin Template. Molecular Pharmacology 2005, 68 (1) , 69-83. https://doi.org/10.1124/mol.104.007823
20. Káthia M. Honório, Albérico B. F. da Silva. A study on the influence of molecular properties in the psychoactivity of cannabinoid compounds. Journal of Molecular Modeling 2005, 11 (3) , 200-209. https://doi.org/10.1007/s00894-005-0243-z
21. Joong‐Youn Shim, William J. Welsh, Allyn C. Howlett. Homology model of the CB 1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction. Peptide Science 2003, 71 (2) , 169-189. https://doi.org/10.1002/bip.10424
22. K.M. Honório, A.B.F. da Silva. A theoretical study on the influence of the frontier orbitals HOMO and LUMO and the size of C4 and C2 substituents in the psychoactivity of cannabinoid compounds. Journal of Molecular Structure: THEOCHEM 2002, 578 (1-3) , 111-117. https://doi.org/10.1016/S0166-1280(01)00690-X
23. Joong-Youn Shim, Elizabeth R. Collantes, William J. Welsh, Allyn C. Howlett. Unified Pharmacophoric Model for Cannabinoids and Aminoalkylindoles. 2000, 201-206. https://doi.org/10.1007/978-1-4615-4141-7_23
24. John W. Huffman, John Liddle, Shu Yu, Mie Mie Aung, Mary E. Abood, Jenny L. Wiley, Billy R. Martin. 3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry 1999, 7 (12) , 2905-2914. https://doi.org/10.1016/S0968-0896(99)00219-9
25. Sumner H Burstein. The Cannabinoid Acids. Pharmacology & Therapeutics 1999, 82 (1) , 87-96. https://doi.org/10.1016/S0163-7258(98)00069-2
26. Allyn C. Howlett. The CB1Cannabinoid Receptor in the Brain. Neurobiology of Disease 1998, 5 (6) , 405-416. https://doi.org/10.1006/nbdi.1998.0215
27. R. Mechoulam, L. Hanuš, Ester Fride. Towards cannabinoid drugs – revisited. 1998, 199-243. https://doi.org/10.1016/S0079-6468(08)70037-7
28. D. P. Dolata, A. L. Parrill, W. P. Walters. CLEW: The Generation of Pharmacophore Hypotheses Through Machine Learning. SAR and QSAR in Environmental Research 1998, 9 (1-2) , 53-81. https://doi.org/10.1080/10629369808039149
29. Nicholas S. Bodor, Ming-ju Huang. Theoretical study of the stereoisomers of tetrahydrocannabinols. International Journal of Quantum Chemistry 1997, 61 (1) , 127-135. https://doi.org/10.1002/(SICI)1097-461X(1997)61:1<127::AID-QUA15>3.0.CO;2-B
30. D. R. Compton, L. S. Harris, A. H. Lichtman, B. R. Martin. Marihuana. 1996, 83-158. https://doi.org/10.1007/978-3-642-60963-3_3
31. Yves Gareau, Claude Dufresne, Michel Gallant, Chantal Rochette, Nicole Sawyer, Deborah M. Slipetz, Nathalie Tremblay, Philip K. Weech, Kathleen M. Metters, Marc Labelle. Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors. Bioorganic & Medicinal Chemistry Letters 1996, 6 (2) , 189-194. https://doi.org/10.1016/0960-894X(95)00573-C
32. Richard E. Musty, Patricia Reggio, Paul Consroe. A review of recent advances in cannabinoid research and the 1994 international symposium on cannabis and the cannabinoids. Life Sciences 1995, 56 (23-24) , 1933-1940. https://doi.org/10.1016/0024-3205(95)00173-4
33. P.H. Reggio, R.D. Bramblett, H. Yuknavich, H.H. Seltzman, D.N. Fleming, S.R. Fernando, L.A. Stevenson, R.G. Pertwee. The design, synthesis and testing of desoxy-CBD: Further evidence for a region of steric interference at the cannabinoid receptor. Life Sciences 1995, 56 (23-24) , 2025-2032. https://doi.org/10.1016/0024-3205(95)00185-9
34. John W. Huffman, W. Kenneth Banner, Grace K. Zoorob, H. Howard Joyner, Patricia H. Reggio, Billy R. Martin, David R. Compton. Stereoselective synthesis of the epimeric Δ7-tetrahydrocannabinols. Tetrahedron 1995, 51 (4) , 1017-1032. https://doi.org/10.1016/0040-4020(94)00995-7
35. Raphael Mechoulam, Lumir Hanuš, Billy R. Martin. Search for endogenous ligands of the cannabinoid receptor. Biochemical Pharmacology 1994, 48 (8) , 1537-1544. https://doi.org/10.1016/0006-2952(94)90197-X
36. John W. Huffman, Dong Dai, Billy R. Martin, David R. Compton. Design, Synthesis and Pharmacology of Cannabimimetic Indoles. Bioorganic & Medicinal Chemistry Letters 1994, 4 (4) , 563-566. https://doi.org/10.1016/S0960-894X(01)80155-4
37. P. H. Reggio. Cannabinoid Receptors and Their Ligands: Ligand—Ligand and Ligand—Receptor Modeling Approaches. , 247-281. https://doi.org/10.1007/3-540-26573-2_8